Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
暂无分享,去创建一个
A. Abdel‐Mageed | D. Schwartz | R. Judd | B. Akingbemi | E. Morrison | F. Bartol | T. Braden | J. Dennis | M. Mansour | Amanda Hazi | India D. Napier